Aurobindo gets UK-MHRA nod for Kazipally facility

Aurobindo Pharma, the Hyderabad-based bulk drug manufacturing
company, has received a certificate of GMP (good manufacturing practice) clearance from the UK Medical Health Regulatory Authority (MHRA) for its unit-VIII situated at Kazipally on the outskirts of Hyderabad.

With this clearance, the active pharmaceutical ingredients (API) site completes one of the important formalities of supplies to be made in the European Union and observer states. The certificate is also recognised by several other regulatory agencies and customers globally.

The facility has already been inspected successfully in the past by the US FDA and WHO-Geneva as well, the company informed the Bombay Stock Exchange (BSE) on Friday.